By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


bioMerieux, Inc. 

100 Rodolphe Street

Durham  North Carolina  27712  U.S.A.
Phone: 800-682-2666 Fax: n/a


A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors. In 2015, revenues reached 1,965 million with 90% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.




CEO: Stefan Willemsen

Key Statistics

Ownership: Private

Web Site: bioMerieux



Gen-Probe Incorporated (Acquired by Hologic)  In September 2004, Gen-Probe entered into non-exclusive licensing agreements with bioMérieux and its affiliates that provide bioMérieux options to access our ribosomal RNA technologies to develop diagnostic products for certain disease targets.

Company News
bioMerieux: FDA Clears Test To Help Manage Antibiotic Treatment For Lower Respiratory Tract Infections And Sepsis 2/24/2017 8:24:58 AM
Quanterix Release: Company Announces Significant Advancements To Strategic Partnership With bioMerieux 1/10/2017 11:32:53 AM
Quanterix Announces Significant Advancements To Strategic Partnership With bioMerieux 1/9/2017 2:31:00 PM
bioMerieux Warns About Potential Inaccurate Test Results When Using NucliSENS easyMAG Magnetic Silica 8/17/2016 7:22:18 AM
bioMerieux Submits 510(K) Application To The bioMerieux For BacT/ALERT VIRTUO Next Generation Automated Blood Culture System 8/3/2016 6:36:24 AM
Sepsis Alliance And bioMerieux, Inc. Partner For Sepsis Awareness And Prevention 4/26/2016 8:44:24 AM
bioMerieux, Inc. And Illumina (ILMN) Announce The Launch Of bioMérieux Episeq, A Revolutionary Next-Generation Sequencing Service For Epidemiological Monitoring Of Bacterial Infections 12/15/2015 11:57:43 AM
LBT Signs Agreement With bioMerieux, Inc. For Previ Isola Automated Plate-Streaking Instrument 8/27/2015 9:48:09 AM
10 Biotech Firms Rapidly Expanding in North Carolina 7/21/2015 5:01:57 AM
bioMerieux, Inc.’s VITEK® MS System Nominated For Prestigious 2014 U.S. Prix Galien Award 10/14/2014 3:03:06 PM